Radnostix, Inc. (INIS)
OTCMKTS · Delayed Price · Currency is USD
0.0600
0.00 (0.00%)
Aug 27, 2026, 2:46 PM EST
Radnostix Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 11.23 | 13.07 | 13.9 | 12.27 | 11.18 | 9.66 |
Revenue Growth | -23.73% | -5.97% | 13.31% | 9.71% | 15.73% | 3.17% |
Gross Profit Gross Profit Growth | 6.04 | 7.7 | 8.65 | 7.38 | 6.29 | 5.74 |
Operating Income Operating Income Growth | -2.9 | -0.96 | 0.01 | -0.78 | -1.2 | -0.24 |
Net Income Net Income Growth | -2.86 | -0.91 | 0.01 | -0.87 | 0.3 | -0.9 |
Earnings Per Share EPS Growth | -0.01 | -0.00 | 0.00 | -0.00 | 0.00 | -0.00 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Theranostics Products Theranostics Products Growth | 5.62 | 6.84 | 8.01 | 6.84 | 6.05 | 4.28 |
Cobalt Products Cobalt Products Growth | 1.51 | 1.75 | 2.37 | 1.04 | 1.16 | 1.35 |
Calibration & Reference Products Calibration & Reference Products Growth | 3.85 | 4.25 | 3.52 | 4.39 | 3.98 | - |
Medical Device Products Medical Device Products Growth | 0.25 | 0.23 | 0.01 | - | - | - |
Total Total Growth | 11.23 | 13.07 | 13.9 | 12.27 | 11.18 | 9.66 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1.2 | 1.7 | 1.95 | 2.69 | 2.38 | 0.47 |
Total Debt Total Debt Growth | 9.21 | 8.9 | 8.36 | 8.34 | 8.11 | 9.18 |
Net Cash (Debt) Net Cash Growth | -8.01 | -7.21 | -6.42 | -5.66 | -5.74 | -8.71 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -0.38 | 0.62 | 0.64 | 0.58 | -1.5 | -0.16 |
Capital Expenditures CapEx Growth | -0.55 | -0.53 | -0.72 | -0.15 | -0.12 | -0.21 |
Free Cash Flow Free Cash Flow Growth | -0.93 | 0.09 | -0.08 | 0.43 | -1.62 | -0.37 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 53.79% | 58.93% | 62.22% | 60.15% | 56.25% | 59.39% |
Operating Margin | -25.84% | -7.32% | 0.05% | -6.33% | -10.76% | -2.49% |
Pretax Margin | -25.52% | -6.95% | 0.06% | -7.08% | 2.71% | -8.17% |
Profit Margin | -25.52% | -6.95% | 0.06% | -7.08% | 2.71% | -9.34% |
FCF Margin | -8.24% | 0.66% | -0.59% | 3.53% | -14.47% | -3.80% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 2100.56 | - | 55.18 | - |
Forward PE | - | 28.10 | 28.10 | 28.10 | 28.10 | 28.10 |
P/FCF Ratio | - | 376.16 | - | 47.96 | - | - |
PS Ratio | 2.80 | 2.48 | 1.30 | 1.70 | 1.50 | 4.89 |